CORRELATION BETWEEN SHORT- AND LONG-TERM EFFECTS OF INTRAVITREAL RANIBIZUMAB THERAPY ON MACULAR EDEMA AFTER BRANCH RETINAL VEIN OCCLUSION

CORRELATION BETWEEN SHORT- AND LONG-TERM EFFECTS OF INTRAVITREAL RANIBIZUMAB THERAPY ON MACULAR EDEMA AFTER BRANCH RETINAL VEIN OCCLUSION - CORRELATION BETWEEN SHORT- AND LONG-TERM EFFECTS OF INTRAVITREAL RANIBIZUMAB THERAPY ON MACULAR EDEMA AFTER BRANCH RETINAL VEIN OCCLUSION

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027003

Enrollment

Registered

2017-04-15

Start date

2013-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

BRANCH RETINAL VEIN OCCLUSION

Interventions

intravitreal ranibizumab injection for 6 months

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The inclusion criteria were the presence of macular edema that involved the fovea after development of BRVO before therapy (foveal thickness [FT] at baseline more than 300 microns), no history of IVR injection, and no history of other treatments for macular edema within the previous 3 months.

Exclusion criteria

Exclusion criteria: The exclusion criteria were the presence of other retinal diseases such as diabetic retinopathy and age-related macular degeneration.

Design outcomes

Primary

Measure	Time frame
The primary endpoint was the change from baseline in the best-corrected visual acuity at 1 day and 6 months after the intravitreal ranibizumab injection.	—

Countries

Japan

Contacts

Public ContactYoshiro Minami

Nayoro city general hospital medical examination section

y37373m@yahoo.co.jp0165433101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026